Dialysis in patients with human immunodeficiency virus infection

Jorge Diego, Jacques J. Bourgoignie

Research output: Chapter in Book/Report/Conference proceedingChapter


The impact of the acquired immunodeficiency syndrome (AIDS) pandemic on the treatment of patients with end-stage renal disease (ESRD) is felt throughout the world, but nowhere more palpably than in the United States. Through June 30, 1997, a cumulative total of 612,078 persons with AIDS were reported to the Centers for Disease Control (CDC). Currently, nearly 240,000 people are living with AIDS in the United States, with an annual incidence of 50,000-60,000 new cases per year. It is estimated that over one million persons are infected with the human immunodeficiency virus (HIV). Worldwide, by the beginning of 1997 a cumulative total of 29.4 million people had been infected with HIV and a cumulative 8.4 million cases of AIDS had been documented (1,2). For the first time, however, the number of deaths among patients with AIDS declined in the United States from 50,700 in 1995 to 39,200 in 1996. As improvements in antiretroviral therapy and prophylaxis of opportunistic infections continue, more patients with AIDS will live longer and may be at risk for developing ESRD (3-5).

Original languageEnglish (US)
Title of host publicationComplications of Dialysis
PublisherCRC Press
Number of pages15
ISBN (Electronic)9780824745295
ISBN (Print)9780824788711
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Dialysis in patients with human immunodeficiency virus infection'. Together they form a unique fingerprint.

Cite this